CAT-2054

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCAT-2054
Drug Alias NameNiacin-eicosapentaenoic acid conjugate (Catabasis)Eicosapentaenoic acid-niacin conjugateCAT-2054
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSterol regulatory element-binding protein 2 inhibitors
TargetsSterol regulatory element-binding protein 2
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCatabasis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstria Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A